ConductScience.org, home

Paper35531007

Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model.

Li Y and 5 others. RSC Adv, 2019. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model. Papers, record 35531007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35531007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model.
PubMed
Journal
RSC Adv
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.44
iCite
Revised in PubMed
2022-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li YYing
2Dong JJunli
3Shang YYinghui
4Zhao QQiangqiang
5Li PPengcheng
6Wu BBinhttps://orcid.org/0000-0001-5619-253X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129204251Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.Oxid Med Cell Longev2017https://conductscience.org/library/papers/29204251PubMed
226481049Hederagenin, a major component of Clematis mandshurica Ruprecht root, attenuates inflammatory responses in RAW 264.7 cells and in mice.Int Immunopharmacol2015https://conductscience.org/library/papers/26481049PubMed
328934669Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.Diabetes Res Clin Pract2017https://conductscience.org/library/papers/28934669PubMed
421617109Globalization of diabetes: the role of diet, lifestyle, and genes.Diabetes Care2011https://conductscience.org/library/papers/21617109PubMed
528067819Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats.Nutrients2017https://conductscience.org/library/papers/28067819PubMed
629669543Diabetes, cardiovascular disease and the microcirculation.Cardiovasc Diabetol2018https://conductscience.org/library/papers/29669543PubMed
726705059Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.J Mol Cell Cardiol2016https://conductscience.org/library/papers/26705059PubMed
823932046An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.Int J Cardiol2013https://conductscience.org/library/papers/23932046PubMed
926557859Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats.Evid Based Complement Alternat Med2015https://conductscience.org/library/papers/26557859PubMed
1027017553Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.Eur J Med Chem2016https://conductscience.org/library/papers/27017553PubMed
1127941647The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.Int J Mol Sci2016https://conductscience.org/library/papers/27941647PubMed
1229449364Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.Circ Res2018https://conductscience.org/library/papers/29449364PubMed
1328776083Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.Diabetologia2018https://conductscience.org/library/papers/28776083PubMed
1427339889Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Nat Rev Endocrinol2016https://conductscience.org/library/papers/27339889PubMed
1521328257Herbal therapy for treating rheumatoid arthritis.Cochrane Database Syst Rev2011https://conductscience.org/library/papers/21328257PubMed
1628395009An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.Cardiovasc Res2017https://conductscience.org/library/papers/28395009PubMed
1721772278Crosstalk in NF-κB signaling pathways.Nat Immunol2011https://conductscience.org/library/papers/21772278PubMed
1826477373Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.J Ethnopharmacol2015https://conductscience.org/library/papers/26477373PubMed
1920586941Herbal medicines and chronic kidney disease.Nephrology (Carlton)2010https://conductscience.org/library/papers/20586941PubMed
2030017632New insights into TGF-β/Smad signaling in tissue fibrosis.Chem Biol Interact2018https://conductscience.org/library/papers/30017632PubMed

See all 31 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
41749398Hederagenin Attenuates Cardiac Remodeling by Targeting Phosphodiesterase 9A.Phytother Res2026https://conductscience.org/library/papers/41749398PubMed
41743998Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms.J Nutr Metab2026https://conductscience.org/library/papers/41743998PubMed
41341866Biomimetic Nanoplatform Based on the Neutrophil Membrane for Targeted Therapy of Spinal Cord Injury.Int J Nanomedicine2025https://conductscience.org/library/papers/41341866PubMed
41140079Recent Advancements in Pentacyclic and Other Terpenoid Derivatives as Anti-inflammatory Agents.Mini Rev Med Chem2026https://conductscience.org/library/papers/41140079PubMed
40771280Therapeutic potential of traditional Chinese medicine in diabetic cardiomyopathy: a review.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40771280PubMed
40511498Hederagenin promotes SIRT6 to attenuate epidural scar formation by aggravating PRMT1 deacetylation.Bone Joint Res2025https://conductscience.org/library/papers/40511498PubMed
40142049Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017-Present).Molecules2025https://conductscience.org/library/papers/40142049PubMed
39383136Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway.PLoS One2024https://conductscience.org/library/papers/39383136PubMed
39082169Efficacy and Mechanism of Core Traditional Chinese Medicines for Treating Malignant Lymphoma based on Efficacy Studies: A Study Supported by Network Pharmacology and Molecular Docking.Curr Pharm Des2024https://conductscience.org/library/papers/39082169PubMed
39021834The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review.Front Pharmacol2024https://conductscience.org/library/papers/39021834PubMed
38962311An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives.Front Pharmacol2024https://conductscience.org/library/papers/38962311PubMed
38927307A Traditional Chinese Medicine, Zhenqi Granule, Potentially Alleviates Dextran Sulfate Sodium-Induced Mouse Colitis Symptoms.Biology (Basel)2024https://conductscience.org/library/papers/38927307PubMed
38707342NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.Heliyon2024https://conductscience.org/library/papers/38707342PubMed
38476892Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles in Perthes disease via the NFκB pathway.Exp Ther Med2024https://conductscience.org/library/papers/38476892PubMed
37955689Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37955689PubMed
37859723Pharmacological overview of hederagenin and its derivatives.RSC Med Chem2023https://conductscience.org/library/papers/37859723PubMed
34234695Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.Front Physiol2021https://conductscience.org/library/papers/34234695PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35531007

GET https://conductscience.org/api/papers/v1/35531007/references?page=2